# Full Product Catalog

Complete reference guide for all compounds in the CULTR library.

## Growth Factors Category

### IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3)
- **Mechanism**: Growth factor signaling; protein synthesis
- **Standard Dose**: 50-100mcg daily
- **Half-life**: 20-30 hours
- **Evidence**: Grade B (strong growth effects)
- **Common Uses**: Lean muscle gain, strength, recovery
- **Stacks Well With**: CJC-1295, Ipamorelin, GHK-Cu
- **Cycle**: 4-6 weeks on, 2-4 weeks off

### ACE-031
- **Mechanism**: Myostatin inhibition; muscle growth deregulation
- **Standard Dose**: 100-300mcg 3x weekly
- **Half-life**: Variable
- **Evidence**: Grade C-D (limited human data)
- **Common Uses**: Muscle hypertrophy without fat gain
- **Special Notes**: Rapid strength; joint stress possible
- **Cycle**: 6-12 weeks

### Follistatin 344
- **Mechanism**: Myostatin antagonist; muscle deregulation
- **Standard Dose**: 100mcg daily for 10 days
- **Half-life**: Hours
- **Evidence**: Grade C-D (mostly animal data)
- **Common Uses**: Significant muscle growth
- **Administration**: Typically pulsed (on/off cycles)
- **Cycle**: Monthly pulses; ongoing protocol

### Sermorelin (GRF 1-29)
- **Mechanism**: GHRH agonist; stimulates GH secretion
- **Standard Dose**: 100-200mcg daily or before bed
- **Half-life**: 7 minutes
- **Evidence**: Grade B (clinical use established)
- **Common Uses**: Natural GH elevation, sleep
- **Side Effects**: Minimal; generally well-tolerated
- **Cycle**: 4-6 weeks on, 1-2 weeks off

### CJC-1295
- **Mechanism**: GHRH with DAC modification; long-acting
- **Standard Dose**: 100-200mcg once or twice weekly
- **Half-life**: 4-6 days (with DAC)
- **Evidence**: Grade B-C
- **Common Uses**: Sustained GH elevation
- **Best Stacked With**: Ipamorelin (synergistic effect)
- **Cycle**: 8-12 weeks

### Ipamorelin
- **Mechanism**: Selective GH secretagogue; minimal cortisol
- **Standard Dose**: 100-200mcg 1-3x daily
- **Half-life**: 2 hours
- **Evidence**: Grade B-C
- **Common Uses**: GH secretion without metabolic stress
- **Best For**: Athletes, endurance, natural GH enhancement
- **Cycle**: 6-8 weeks on, 2 weeks off

## Repair & Recovery Category

### BPC-157 (Body Protection Compound-157)
- **Mechanism**: Angiogenesis; nerve growth; anti-inflammatory
- **Standard Dose**: 250mcg 1-2x daily
- **Half-life**: Hours
- **Evidence**: Grade B-C (strong preclinical data)
- **Routes**: IM, SQ, Intranasal, Oral
- **Common Uses**: Tendon healing, joint recovery, GI health
- **Cycle**: 4-6 weeks minimum for best results

### TB-500 (Thymosin Beta-4)
- **Mechanism**: Actin-binding; growth factor upregulation
- **Standard Dose**: 2mg weekly x 4 weeks, then 1mg weekly
- **Half-life**: Hours
- **Evidence**: Grade C (animal data strong)
- **Routes**: Subcutaneous, Intramuscular
- **Common Uses**: Athletic recovery, tissue repair
- **Best For**: General health maintenance post-injury
- **Cycle**: 8-12 weeks

### GHK-Cu (Copper Peptide Complex)
- **Mechanism**: Collagen synthesis; tissue remodeling
- **Standard Dose**: 200-400mcg daily
- **Half-life**: Hours
- **Evidence**: Grade B (clinical use established)
- **Routes**: Topical, Subcutaneous, Intranasal
- **Common Uses**: Skin health, collagen, joint support
- **Best For**: Long-term collagen enhancement
- **Cycle**: Ongoing use is common

### GLOW Blend
- **Mechanism**: Multiple peptides; comprehensive recovery
- **Standard Dose**: Variable (follows manufacturer guidelines)
- **Evidence**: Grade C
- **Common Uses**: Athletic recovery, general wellness
- **Composition**: BPC-157 + TB-500 + additional components
- **Cycle**: 8-12 weeks

### Elamipretide (SS-31)
- **Mechanism**: Mitochondrial targeting; energy optimization
- **Standard Dose**: 1-5mg daily
- **Half-life**: Hours
- **Evidence**: Grade C-D (emerging)
- **Routes**: Intravenous, Subcutaneous
- **Common Uses**: Cellular energy, fatigue reduction
- **Best For**: Mitochondrial dysfunction, aging
- **Cycle**: Variable

### TP508 (Chrysalin)
- **Mechanism**: Wound healing; angiogenesis
- **Standard Dose**: 5mg subcutaneously
- **Half-life**: Hours
- **Evidence**: Grade C
- **Routes**: Subcutaneous, Topical
- **Common Uses**: Acute wound healing, tissue damage
- **Best For**: Injury recovery, regeneration

## Metabolic Category

### Cagrilintide
- **Mechanism**: Amylin receptor agonist; dual GI/CNS effects
- **Standard Dose**: 250-500mcg weekly
- **Half-life**: Days
- **Evidence**: Grade C (emerging)
- **Routes**: Subcutaneous
- **Common Uses**: Weight loss, appetite suppression
- **Best For**: Significant fat loss goals
- **Cycle**: 8-12+ weeks

### Semaglutide
- **Mechanism**: GLP-1 receptor agonist; satiety, metabolic
- **Standard Dose**: 0.25-1mg weekly
- **Half-life**: 7 days
- **Evidence**: Grade B+ (strong clinical data)
- **Routes**: Subcutaneous
- **Common Uses**: Weight loss, glucose control
- **Best For**: Metabolic optimization, fat loss
- **Cycle**: Ongoing use possible

### FRAG 176-191 + AOD 9604
- **Mechanism**: HGH fragment; direct fat mobilization
- **Standard Dose**: 100-200mcg daily (split doses)
- **Half-life**: 1-2 hours
- **Evidence**: Grade C-D
- **Routes**: Subcutaneous, Intramuscular
- **Common Uses**: Fat loss without muscle loss
- **Best For**: Body recomposition
- **Cycle**: 6-8 weeks on, 2 weeks off

## Bioregulator Category

### Epitalon
- **Mechanism**: Telomerase activation; pineal function
- **Standard Dose**: 3-10mg daily or every 3 days
- **Half-life**: Hours
- **Evidence**: Grade C (Russian clinical data)
- **Routes**: Subcutaneous, Intranasal
- **Common Uses**: Anti-aging, longevity, sleep
- **Best For**: Long-term health optimization
- **Cycle**: 6-12 weeks minimum

### DSIP
- **Mechanism**: Sleep-promoting peptide; delta-wave enhancement
- **Standard Dose**: 100-500mcg at bedtime or 1mg daily
- **Half-life**: Hours
- **Evidence**: Grade C
- **Routes**: Intranasal, Subcutaneous, Intravenous
- **Common Uses**: Sleep quality, recovery enhancement
- **Best For**: Sleep optimization
- **Cycle**: 4-8 weeks on, 1-2 weeks off

### Thymosin Alpha-1
- **Mechanism**: T-cell stimulation; immune upregulation
- **Standard Dose**: 1-1.6mg twice weekly
- **Half-life**: Hours
- **Evidence**: Grade C (established safety)
- **Routes**: Subcutaneous, Intramuscular
- **Common Uses**: Immune support, general health
- **Best For**: Immune system optimization
- **Cycle**: 4-12 weeks, can be ongoing

### SEMAX
- **Mechanism**: ACTH analog; nootropic, neuroprotective
- **Standard Dose**: 250-600mcg daily (intranasal)
- **Half-life**: Hours
- **Evidence**: Grade C (Russian/international use)
- **Routes**: Intranasal (primarily)
- **Common Uses**: Cognitive enhancement, memory
- **Best For**: Mental clarity, learning
- **Cycle**: 4-8 weeks on, 1-2 weeks off

### SELANK
- **Mechanism**: Enkephalin analog; anxiolytic, mood support
- **Standard Dose**: 250-500mcg daily (intranasal)
- **Half-life**: Hours
- **Evidence**: Grade C
- **Routes**: Intranasal (primarily)
- **Common Uses**: Anxiety reduction, mood balance
- **Best For**: Mental health support
- **Cycle**: 4-8 weeks on, ongoing possible

### Humanin
- **Mechanism**: Neuroprotection; mitochondrial support
- **Standard Dose**: 100-200mcg daily
- **Half-life**: Hours
- **Evidence**: Grade D (emerging)
- **Routes**: Subcutaneous, Intranasal
- **Common Uses**: Neuroprotection, cognitive aging
- **Best For**: Neurological health, aging prevention
- **Cycle**: Variable; research ongoing

---

## Optimal Timing Guide — All Products

### MORNING (FASTED OR EARLY DAY)

| Peptide | Timing | Notes |
|---------|--------|-------|
| AOD-9604 / FRAG 176-191 | Morning or pre-cardio | Fat loss; empty stomach |
| Epitalon | Morning | Circadian support |
| SEMAX | Morning/early afternoon | Cognitive; avoid late PM |
| SELANK | Morning or as needed | Anxiolytic; avoid evening |
| Thymosin Alpha-1 | Morning | Immune rhythm support |
| Elamipretide | Morning (fasted) | Mitochondrial energy |
| Cagrilintide / Semaglutide | Same day weekly | Consistent timing |

### EVENING / PRE-SLEEP

| Peptide | Timing | Notes |
|---------|--------|-------|
| Sermorelin | Pre-sleep | GH pulse; empty stomach 2-3h |
| CJC-1295 + Ipamorelin | Pre-sleep | Synergistic GH pulse; fasted |
| DSIP | 30-60 min before bed | Delta sleep induction |
| GHK-Cu | Evening | Repair, skin regeneration |

### PRE-WORKOUT / DAYTIME

| Peptide | Timing | Notes |
|---------|--------|-------|
| IGF-1 LR3 | Pre-workout | Muscle signaling; avoid food 2-3h |
| ACE-031 | Pre-workout or AM | Myostatin inhibition |
| BPC-157 | Near training (optional) | Can dose near injury site |
| TB-500 | Flexible | Recovery support |

### FLEXIBLE / SITUATIONAL

| Peptide | Timing | Notes |
|---------|--------|-------|
| PT-141 | 30-60 min before desired effect | Sexual function |
| Kisspeptin-10 | 30-60 min before desired effect | GnRH trigger |
| Melanotan-1/2 | Pre-sun exposure | 30-60 min before UV |
| Oxytocin | As needed | Social/bonding contexts |
| BPC-157 / TB-500 | Flexible | Consistency > exact timing |

### CRITICAL TIMING RULES

| Rule | Guideline |
|------|-----------|
| **GH-related peptides** | Avoid food 2-3 hours before; insulin blunts GH release |
| **Metabolic/fat loss** | Fasted morning or pre-cardio; consistency > exact hour |
| **CNS peptides (SEMAX, SELANK)** | Avoid late night to prevent sleep disruption |
| **Sleep peptides (DSIP)** | 30-60 min before bed; do not combine with sedatives |
| **GLP-1 weekly injections** | Same day and time every week |
| **Repair peptides (BPC, TB-500)** | Timing flexible; some prefer near injury site |

---

## General Administration Guidelines

### Reconstitution
- Use bacteriostatic water (0.9% benzyl alcohol)
- Mix gently; avoid vigorous shaking
- Solution typically stable 30 days refrigerated
- Label with reconstitution date

### Injection Technique
- **SQ**: Subcutaneous layer (belly, thigh, arm)
- **IM**: Intramuscular (glute, quad, deltoid)
- Rotate injection sites to avoid lipohypertrophy
- Maintain sterile technique always

### Storage
- **Powder**: Refrigerated (2-8°C) or room temp (varies)
- **Reconstituted**: Always refrigerated (2-8°C)
- Away from light exposure
- Check for clarity/discoloration before use

## Important Medical Disclaimer

All information provided is for educational and research purposes only. These compounds are not approved for human consumption in most jurisdictions. This information should not be construed as medical advice. Always consult with qualified healthcare providers before considering any compound. CULTR Health does not recommend, endorse, or provide medical guidance for human use of these substances.
